GO
Loading...

Drug Retail

More

  • Sarepta Therapeutics CEO Chris Garabedian discusses the prospects for what he calls a "potential accelerated approval" for its Duchenne muscular dystrophy drug Eteplirsen.

  • Sarepta muscle drug faces challenges     Monday, 21 Apr 2014 | 2:04 PM ET

    Sarepta Therapeutics is developing a drug for Duchenne muscular dystrophy. Its CEO Chris Garabedian discusses challenges the drug Eteplirsen has faced before the FDA.

  • April 14- U.S. drugstore chain operator Walgreen Co is under pressure from a group of shareholders to consider relocating to Europe to gain tax benefits, the Financial Times reported.

  • April 14- U.S. drugstore chain operator Walgreen Co is under pressure from a group of shareholders to consider relocating to Europe to gain tax benefits, the Financial Times reported.

  • Walgreens urged to leave US to gain tax benefit Monday, 14 Apr 2014 | 8:40 AM ET

    Walgreens has come under pressure from an influential group of its shareholders, who want the US pharmacy chain to consider relocating to Europe, in what would be one of the largest tax inversions ever attempted. The FT reports.

  • Hep C breakthrough     Thursday, 10 Apr 2014 | 2:53 PM ET

    CNBC contributor Barbara Ryan provides insight into new guidelines from the World Health Organization, which strongly endorses two new hepatitis c drugs.

  • April 10- Rite Aid Corp, the third-largest U.S. drugstore operator, forecast fiscal 2015 sales above analysts' estimates as it benefits from the launch of new generic drugs and enrolls more customers in its loyalty programs.

  • Another profitable quarter, Rite Aid breaks out Thursday, 10 Apr 2014 | 8:27 AM ET

    Rite Aid has left the recovery ward and appears ready to break into a sprint after booking its sixth straight quarterly profit and making a deal to strengthen the drugstore chain's foothold in the burgeoning health clinic market.

  • Flu drug stockpiles a waste of money: Report Thursday, 10 Apr 2014 | 6:27 AM ET

    The U.K. and U.S. governments spent millions stockpiling a flu drug that is no better than paracetamol, according to a new report.

  • Ultragenyx is now up around 150 percent from its IPO price. Its CEO Dr. Emil Kakkis provides insight on the development of its drugs, and just how committed the company is to treating patients with the diseases its drugs treat.

  • FTI Consulting managing director Barbara Ryan provides insight on new drugs showing dramatic improvement in the standard of care for high cholesterol.

  • New class of cholesterol drugs     Monday, 31 Mar 2014 | 1:19 PM ET

    CNBC's Dominic Chu reports on news out about a special new drug that could combat cholesterol.

  • CNBC's Steve Liesman reports how participants of CNBC's All-America Economic Survey view Obamacare, and raising the minimum wage.

  • CNBC's All-America survey: Marijuana views     Wednesday, 26 Mar 2014 | 1:22 PM ET

    CNBC's Steve Liesman reports 56 percent of participants supported the legalization of marijuana in their town.

  • Why drug treatment prices vary     Wednesday, 26 Mar 2014 | 1:08 PM ET

    The U.S. government is prohibited by law from negotiating drug prices, reports CNBC's Sheila Dharmarajan.

  • NJ pot bill: Garden State going green?     Tuesday, 25 Mar 2014 | 11:32 AM ET

    Senator Nicholas Scutari, D-N.J., discusses the bill he introduced that would allow adults to purchase and grow a limited amount of marijuana for personal use in New Jersey.

  • March 25- Walgreen Co, operator of the largest U.S. drugstore chain, on Tuesday reported a rise in quarterly sales but said a slowdown in the introduction of higher-profit generic medicines cut into its gross profit margin.

  • The group sent a letter on Sunday to chief executive officers of Wal-Mart Stores Inc, supermarket operators Kroger Co, Safeway Inc, which operate pharmacies, and drugstore chains Walgreen Co and Rite Aid Corp.. Wal-Mart, Walgreen, Rite Aid and Kroger all said they were reviewing the letter, while Safeway did not respond to requests for comment.

  • The companies receiving a letter on Sunday from the group were Wal-Mart Stores Inc, supermarket operators Kroger Co, Safeway Inc, which operate pharmacies, and drugstore chains Walgreen Co and Rite Aid Corp..

  • ADHD big money for big pharma     Wednesday, 12 Mar 2014 | 2:49 PM ET

    CNBC's Sheila Dharmarajan reports 15 percent of high school aged children are diagnosed with ADHD, or attention deficit hyperactivity disorder.

Most Popular Video

Wednesday, 23 Apr 2014 | 8:12 AM ET

Anthony DiClemente, Nomura senior analyst, shares his upbeat outlook on the social media giant, as advertising dollars continue to shift towards digital media.

Wednesday, 23 Apr 2014 | 7:30 AM ET

Boeing's profit margin on the commercial side improves to 11.8 percent, reports CNBC's Phil LeBeau with a break down on Boeing's quarterly results.

Wednesday, 23 Apr 2014 | 7:17 AM ET

Jon Moeller, Procter & Gamble CFO, breaks down the company's third quarter results of $1.04 EPS ex-items on revenues of $20.56 billion and weighs in on where the company sees global growth.